Results
|
1.
|
Do molecular profiles of primary versus metastatic radioiodine refractory differentiated thyroid cancer differ? MedStar authors:
- Bikas, Athanasios
- Burman, Kenneth D
- Chittimoju, Sanjita
- Gomes Lima, Christiane J
- Jonklaas, Jacqueline
- Lee, Wen
- Parikh, Tanvi
- Rao, Sarika
- Shobab, Leila
- Wartofsky, Leonard
- Wexler, Jason A
- Wu, Di
- Ylli, Dorina
Year: 2019
Department:
- Medicine/Endocrinology
- Pathology
All authors: - Gomes-Lima C, Shobab L, Wu D, Yll D, Bikas A, Avadhanula S, Parikh T, Chittimoju S, McCoy M, Rao S, Feldman R, Lee W, Wexler J, Jonklaas J, Wartofsky L, Burman K.
|
|
2.
|
Radioiodine dosimetry practices in the united states for differentiated thyroid cancer: preliminary report. MedStar authors:
- Burman, Kenneth D
- Gomes Lima, Christiane J
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2019
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
- Pathology
All authors: - Wu D...[Ylli D, Gomes-Lima C, Burman K, Wartofsky L, Van Nostrand], et al.
|
|
3.
|
|
|
4.
|
|
|
5.
|
New use for an old isotope. MedStar authors:
- Burman, Kenneth D
- Gomes Lima, Christiane J
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2018
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Gomes Lima C
- Van Nostrand D.
- Wartofsky L
- Wu D
- Ylli D
|
|
6.
|
|
|
7.
|
|
|
8.
|
Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors:
- Burman, Kenneth D
- Kulkarni, Kanchan P
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
Year: 2018
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Kharazi P
- Khorjekar G
- Kulkarni K
- Moreau S
- Van Nostrand D.
- Wartofsky L
- Wu D
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Assessment of serial comprehensive metabolic Panel ats following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
- Bikas, Athanasios
- Boulougoura, Afroditi
- Burman, Kenneth D
- Mirza, Faryal
- Vachhani, Shivangi
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2016
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K
|
|
17.
|
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D
|
|
18.
|
Assessment of serial complete blood counts following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
- Bikas, A
- Boyle, Lisa M
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Burman K, Desale S, Mete M, Boyle L, Wartofsky L, Van Nostrand D
|
|
19.
|
|
|
20.
|
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. MedStar authors:
- Burman, Kenneth D
- Klubo-Gwiezdzinska, Joanna
- Mete, Mihriye
- Wartofsky, Leonard
Year: 2013
All authors: - Klubo-Gwiezdzinska J, Costello J, Patel A, Bauer AJ, Jensen KE, Mete M, Burman K, Wartofsky L
|